Document Detail

Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance.
MedLine Citation:
PMID:  17251084     Owner:  NLM     Status:  MEDLINE    
Before a recommendation for antimalarial drug use in pregnancy is made, it is essential that we understand the potential risks involved and have mechanisms in place to monitor risk during treatment. This requires data on drug disposition during pregnancy and potential toxicological liabilities to the developing fetus and mother. In most cases this information is not available. We review the reproductive toxicology of the main antimalarial drug classes in use or under development. Preclinical data are presented if appropriate, but as human experience overrides such data, in instances in which preclinical studies do not correlate with the human experience the data are reviewed only briefly. Additionally, we highlight the lack of appropriate drug disposition data in pregnancy and suggest mechanisms that can be used to capture data on risk after drug treatment in pregnancy.
Stephen A Ward; Esperanca J P Sevene; Ian M Hastings; François Nosten; Rose McGready
Related Documents :
2375184 - Catamnestic investigations in children with congenital hydrocephalus.
3785754 - Phenobarbital during pregnancy in mouse and man.
20627904 - Sex-specific associations between cortisol and birth weight in pregnancies complicated ...
2325044 - Status epilepticus in pregnancy. a case report.
12781844 - Reactive oxygen species in pregnant rats: effects of exercise and thermal stress.
10503934 - Elevated leptin concentrations in pregnancy and lactation: possible role as a modulator...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Lancet. Infectious diseases     Volume:  7     ISSN:  1473-3099     ISO Abbreviation:  Lancet Infect Dis     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-01-25     Completed Date:  2007-03-02     Revised Date:  2014-08-15    
Medline Journal Info:
Nlm Unique ID:  101130150     Medline TA:  Lancet Infect Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  136-44     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antimalarials* / adverse effects,  pharmacokinetics,  therapeutic use
Malaria, Falciparum / drug therapy*,  prevention & control
Pregnancy Complications, Parasitic / drug therapy*,  prevention & control
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reducing the burden of malaria in pregnancy by preventive strategies.
Next Document:  From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy...